rs756624928
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM2PM5BP4_Moderate
The NM_198253.3(TERT):c.895G>T(p.Val299Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000703 in 1,421,920 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V299M) has been classified as Pathogenic.
Frequency
Consequence
NM_198253.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TERT | NM_198253.3 | c.895G>T | p.Val299Leu | missense_variant | 2/16 | ENST00000310581.10 | NP_937983.2 | |
TERT | NM_001193376.3 | c.895G>T | p.Val299Leu | missense_variant | 2/15 | NP_001180305.1 | ||
TERT | NR_149162.3 | n.974G>T | non_coding_transcript_exon_variant | 2/13 | ||||
TERT | NR_149163.3 | n.974G>T | non_coding_transcript_exon_variant | 2/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TERT | ENST00000310581.10 | c.895G>T | p.Val299Leu | missense_variant | 2/16 | 1 | NM_198253.3 | ENSP00000309572 | P2 | |
TERT | ENST00000334602.10 | c.895G>T | p.Val299Leu | missense_variant | 2/15 | 1 | ENSP00000334346 | A2 | ||
TERT | ENST00000460137.6 | c.895G>T | p.Val299Leu | missense_variant, NMD_transcript_variant | 2/13 | 1 | ENSP00000425003 | |||
TERT | ENST00000656021.1 | c.895G>T | p.Val299Leu | missense_variant, NMD_transcript_variant | 2/17 | ENSP00000499759 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD4 exome AF: 7.03e-7 AC: 1AN: 1421920Hom.: 0 Cov.: 35 AF XY: 0.00 AC XY: 0AN XY: 704628
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Idiopathic Pulmonary Fibrosis;C3151443:Dyskeratosis congenita, autosomal dominant 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 28, 2018 | This variant has not been reported in the literature in individuals with TERT-related disease. This sequence change replaces valine with leucine at codon 299 of the TERT protein (p.Val299Leu). The valine residue is weakly conserved and there is a small physicochemical difference between valine and leucine. This variant is not present in population databases (ExAC no frequency). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The leucine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Dyskeratosis congenita Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 27, 2022 | The p.V299L variant (also known as c.895G>T), located in coding exon 2 of the TERT gene, results from a G to T substitution at nucleotide position 895. The valine at codon 299 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at